Skip to main content
Figure 2 | Stem Cell Research & Therapy

Figure 2

From: Mesenchymal stem cell-derived microparticles ameliorate peritubular capillary rarefaction via inhibition of endothelial-mesenchymal transition and decrease tubulointerstitial fibrosis in unilateral ureteral obstruction

Figure 2

In vitro cell proliferation effects of MPs. Cell proliferation of HUVEC non-pretreated control (‘Control’), pretreated with TGF-β1 alone, with TGF-β1 treatment simultaneously with KMSC-derived MP, and MPs preincubated with RNase. Non-treated control was expressed as ‘Control.’ Results are expressed as the mean ± SE of three different experiments. The Kruskal-Wallis test was performed; * P <0.05 versus non-treated control. # P <0.05 versus TGF-β1 alone. HUVEC, human umbilical vein endothelial cells; KMSC, kidney-derived mesenchymal stem cells; MPs, microparticles; SE, standard error; TGF-β1, transforming growth factor- β1.

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512